EBS Historical Earnings image   This EBS historical earnings page last updated 8/3/2022
EBS Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/1/20220.24B
Q1 20224/28/20220.31B
Q4 20212/24/20220.72B
Q3 202111/4/20210.33B
Q2 20217/29/20210.40B
Q1 20214/29/20210.34B
Q4 20202/18/20210.58B
Q3 202011/5/20200.39B
Q2 20207/30/20200.39B
Q1 20204/30/20200.19B
Q4 20192/20/20200.36B
Q3 201911/6/20190.31B
Q2 20198/1/20190.24B
Q1 20195/2/20190.19B
Q4 20182/21/2019270.70M
Q3 201811/1/2018173.65M
Q2 20188/2/2018220.20M
Q1 20185/3/2018117.81M
Q4 20172/22/2018193.81M
Q3 201711/2/2017149.43M
Q2 20178/3/2017100.77M
Q1 20175/4/2017116.86M
Q4 20162/23/2017151.66M
Q3 201611/7/2016142.91M
Q2 20168/4/2016101.49M
Q1 20165/5/2016111.00M
Q4 20152/25/2016168.10M
Q3 201511/5/2015164.94M
Q2 20158/6/2015126.11M
Q1 20155/7/201563.63M
Q4 20143/5/2015147.97M
Q3 201411/6/2014137.95M
Q2 20148/7/2014110.30M
Q1 20145/8/201453.90M
Q4 20133/6/201498.10M
Q3 201311/7/201389.10M
Q2 20138/5/201382.46M
Q1 20135/2/201343.10M
Q4 20123/7/201394.60M
Q3 201211/1/20120.07B
Q2 20128/2/201270.40M
Q1 20125/8/201250.31M
EBS Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q2 20228/1/2022-0.860
Q1 20224/28/20220.180
Q4 20212/24/20224.500
Q3 202111/4/2021-0.360
Q2 20217/29/20210.330
Q1 20214/29/20211.530
Q4 20202/18/20213.670
Q3 202011/5/20202.190
Q2 20207/30/20201.980
Q1 20204/30/20200.010
Q4 20192/20/20201.570
Q3 201911/6/20191.210
Q2 20198/1/2019-0.120
Q1 20195/2/2019-0.130
Q4 20182/21/20190.75
Q3 201811/1/20180.55
Q2 20188/2/20181.07
Q1 20185/3/2018-0.03
Q4 20172/22/20180.74
Q3 201711/2/20170.74
Q2 20178/3/20170.11
Q1 20175/4/20170.29
Q4 20162/23/20170.74
Q3 201611/7/20160.58
Q2 20168/4/2016-0.18
Q1 20165/5/20160.16
Q4 20152/25/20160.78
Q3 201511/5/20150.83
Q2 20158/6/20150.36
Q1 20155/7/2015-0.5
Q4 20143/5/20150.75
Q3 201411/6/20140.67
Q2 20148/7/20140.13
Q1 20145/8/2014-0.55
Q4 20133/6/20140.41
Q3 201311/7/20130.36
Q2 20138/5/20130.29
Q1 20135/2/2013-0.22
Q4 20123/7/20130.45
Q3 201211/1/20120.18
Q2 20128/2/20120.21
Q1 20125/8/2012-0.19
Quotes delayed 20 minutes

Email EnvelopeFree EBS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Emergent BioSolutions (EBS) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ECOR Historical Earnings
EDIT Historical Earnings
EGRX Historical Earnings
EHC Historical Earnings
EIGR Historical Earnings
EKSO Historical Earnings
ELAN Historical Earnings
ELDN Historical Earnings
ELEV Historical Earnings
ELOX Historical Earnings
What was the record high EBS historical earnings result?
In terms of earnings or revenue, what is the best EBS historical earnings result that Emergent BioSolutions has ever posted, and when?

✔️Accepted answer: Within our data set, the highest EBS historical earnings result was set in Q4 2021, when Emergent BioSolutions posted results of 4.500/share. The most successful revenue quarter within our data set was Q4 2021 when Emergent BioSolutions reported revenue of 0.72B.

What was the lowest Emergent BioSolutions historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest EBS has reported, and when?

✔️Accepted answer: Within our data set, the lowest EBS historical earnings result was set in Q2 2022, when Emergent BioSolutions posted results of -0.860/share. The smallest revenue quarter within our data set was Q1 2013 when Emergent BioSolutions reported revenue of 43.10M.

On this page we presented the EBS historical earnings date information for Emergent BioSolutions. Reviewing that EBS Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2021, when EBS posted adjusted EPS of 4.500/share. Meanwhile the lowest EBS historical earnings result was in Q2 2022, when EBS posted adjusted EPS of -0.860/share. Moving to Emergent BioSolutionss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2021 when EBS reported 0.72B in revenue, while the smallest revenue quarter was Q1 2013 when EBS reported 43.10M in revenue.

For self directed investors doing their due diligence on EBS or any other given stock, their research can benefit from looking into all of the Emergent BioSolutions historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Emergent BioSolutions historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for EBS. Thanks for visiting, and the next time you need to research EBS historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Funds Holding BRK, TECD Options Chain, DLLR Historical Stock Prices.

 

EBS Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.